Stay updated on Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision: v3.6.3 is now shown, replacing v3.6.0, signaling a version update to the page's underlying system. This change updates metadata and does not alter the study details or core content.
    Difference
    0.0%
    Check dated 2026-06-30T02:36:14.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added recruitment status note and new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revised Intervention/Treatment section; removed the older 'Intervention / Treatment' heading and the 'Revision: v3.5.5' note.
    Difference
    0.2%
    Check dated 2026-06-15T23:54:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small update to the page template or system, with no apparent changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-09T02:11:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The Locations section was updated to replace Kharkivs’ka Oblast’ with Kharkiv Oblast and to add a new entry for Kharkiv, Kharkiv Oblast, Ukraine, 61070; the former Kharkivs’ka Oblast’ entry (and its city/ZIP) was removed.
    Difference
    0.0%
    Check dated 2026-06-01T23:07:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision tag on the study page updated from v3.5.3 to v3.5.4. This reflects a new internal update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-05-18T13:38:29.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s revision label was updated from version v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-27T08:01:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.